Firm Leadership

advertisement
Firm Leadership
August 2013
WASHINGTON DC
AUSTIN
SAN FRANCISCO
1
History
ADVI, a merger of HillCo HEALTH and AccelusHealth Partners was
founded by Marc Samuels and Lawrence Leisure in 2013.
Our team members translate the value of client products and services into
the language and currency of payers, both public and private. In doing so
we create value for new or existing clients by accelerating time to revenue
and profitability with a higher degree of market certainty.
2
ADVI IS UNIQUE: Government, scientific,
industry, payer, and professional consultancy
experience and expertise in one company
3
ADVI Team Members
Consulting




Life Sciences
Digital Health
Managed Care
Services
Research




Market Research
Due Diligence
Idea Generation (B2B, B2G)
Analytics
4
Marc Samuels, JD, MPH
President and Chief Executive Officer
Marc Samuels is the President and CEO of ADVI (formerly HillCo HEALTH). Samuels is
responsible for the strategic vision, leadership and operational execution of the Company, as well as development
and execution strategies designed to grow business outside of North America. He provides senior relationship
management for the firm’s top clients across life sciences, digital health, managed care and services. He is a
graduate of The University of Texas School of Law, Yale School of Medicine and the University of Michigan.
Worked at the highest levels of national and Texas state politics
White House Office of Policy Development
Vice President’s Office
Pentagon Office of Health Affairs
Texas Health & Human Services Commission
Office of the Governor, State of Texas
Involved in many of the most seminal policy issues across public and private payers
Coding and payment of molecular diagnostics
Drug Payment Reform
Quality and registry issues
Key overage decisions: EMEND, ESAs, EXACT SCIENCES, TAVR, VISUDYNE, ZEVALIN, PROVENGE
Spoken and Published: In Vivo, Journal of Oncology Practice, Medical Economics, Health Systems Review;
Managed Care Answer Book , HMO and Capitation Answer Book, published by Panel Publishers, New York
5
Lawrence Leisure
Chairman
Larry Leisure is the Chairman at ADVI. He also serves as a venture partner at Kleiner Perkins
Caufield & Byers. He received his AB in economics from Stanford University and his MBA in finance from the
University of California, Los Angeles.
Distinguished career in healthcare serving in a number of senior consulting and management roles
 Global Managing Partner, Accenture
 Global Managing Partner, Towers Watson
 Senior Vice President, Kaiser Permanente
Client partner to many of the largest US health plans and PBMs
 Aetna, CIGNA, UnitedHealth, and WellPoint
 Caremark, ESI/MEDCO, MedImpact
Well known industry leader and innovator
 Co-founded Healthspottr, a new media focused on the acceleration of innovation in health care
 Sits on the boards of several Silicon Valley health information and bioscience companies including
Crescendo Bioscience, Medpedia, Navigenics, and Tethys Bioscience
6
Michael Beebe
Senior Vice President
Michael Beebe, Senior Vice President, joined ADVI in 2008. Mr. Beebe advises clients on all
aspects of reimbursement and strategic policy planning, including specific coding strategies in the physician
office and the hospital or other health care provider settings. He directs ADVI’s device and diagnostic
practices. Mr. Beebe has a Bachelor of Arts from Penn State University and a Master’s Degree from Boston
University.
Long and deep physician specialty relationships
Mr. Beebe spent 14 years at the AMA prior to joining ADVI; his most recent position was Director of CPT
He was a central participant in AMA advocacy efforts involving public and private coverage, coding and
reimbursement issues; including provider class action litigation, CMS physician payment negotiations, and
local coverage determinations
Senior Social Scientist in Physician Payment Systems where he was primary staff to the AMA/Specialty
Society RVS Update Committee (RUC)
Responsible for or involved in many of the most seminal product and service coding decisions
Molecular and companion diagnostics – created MAAA and NGS coding nomenclatures
Spinal techniques
Vaccines
Tele-monitoring
Wound Care and Skin substitutes
Cardiac Procedures, including TAVR and minimally invasive
7
Angela Lively
Senior Vice President
Angela Lively, Senior Vice President, leads the firm’s drugs and biologics practice.
commercialization practice and has spent her career advising top biopharmaceutical companies on issues
affecting patient access to new and innovative products. Ms. Lively completed her Masters in Social Work
Social Policy with a concentration in health policy from The Catholic University of America and has a
Bachelor of Arts degree in Psychology and Sociology from Baylor University.
Significant Industry Expertise
 Amgen
 Abbott
Profound Consulting Experience
 Avalere
 DK Pierce
 Covance
Leader in Innovative Thinking
 Evidence development, local and national payer strategy (Medicare, Medicaid, and commercial
insurance), coding recommendations and support, advocacy development, and health policy change
 Focused in the areas of nephrology, oncology, primary care, internal medicine, and cardiology
 Projects include self-administered biologics, physician-administered drugs and biologics, dialysis
supplies, and inpatient and outpatient products with unique drug delivery systems
8
Louis Jacques, M.D.
Senior Vice President and Chief Innovation Officer
Louis Jacques leads ADVI's growth efforts at the FDA, in pre-launch clinical trial development and
measurement of clinical effectiveness and utility. Louis is spearheading an all client initiative focused on a top down
commitment to change, recognizing that public and private payer "pay for value constructs" will require evidencing
value and tying remuneration of our client's offerings to the evidencing of that value. Jacques is also a Senior Advisor
to Warburg Pincus. Dr. Jacques is a graduate of Georgetown University and The University of Maryland School of
Medicine.
A
Distinguished Career in Government Service and in Medicine
 Director, Coverage & Analysis Group (CAG), Centers for Medicare and Medicaid Services (CMS) since 2009
 Led CMS collaborations with Food and Drug Administration (FDA) including Entrepreneurs in Residence Program
 Practiced medicine as an attending physician for almost 20 years, and was an Associate Dean at Georgetown
University School of Medicine before coming to CMS
Passionate about Change and Innovation
 Implemented Coverage with Evidence Development (CED) under the Medicare program
 Co-created joint parallel review pilot between CMS and FDA
 Responsible for updating Medicare coverage in FDA IDE trials
 Coauthored over 60 Medicare National Coverage Determinations
 Developed program oversight of the Local Coverage Determination process
Recognized as a Leader, Speechifier, and Writer
 Invited speaker at national policy and professional society meetings nationally and abroad
 Authored or coauthored original research and commentaries in peer reviewed medical journals
 Awarded FDA Leveraging/Collaboration Award (TVT Registry Team) 2013; FDA Parallel Review Team Award 2012;
CMS Leadership Awards 2006, 2010; Golden Apple (Teaching Award - Georgetown University School of Medicine)
9
Tamar Thompson
Vice President
Tamar Thompson is a Vice President at ADVI and leads agency engagement across firm
specializations. She has more than 15 years of leadership experience in health care, including the ability to
develop strategic and tactical recommendations to ensure optimal reimbursement and market access for
products. Ms. Thompson holds a M.S. in Health Sciences with a concentration in Public Health from Trident
University in Cypress California. She also has active certifications from the American Health Information
Management Association (AHIMA) as a Certified Coding Specialist (CCS) and Certified Coding Specialist –
Physician Based (CCS-P).
Broad Cross-Specialization
 Kimbell & Associates, a premier lobbying firm
 Avalere, a leading advisory services firm
 GE
 Bracco Diagnostics
 Molecular Insight Pharmaceuticals
Extensive experience
 Government agencies (HHS, CMS, FDA, PCORI, MEDPAC, MACPAC, IOM, OMB, CBO)
 Private payers
 Congressional leaders
 Patient and Physician Stakeholders
Involvement in scoring and legislative drafting
Leader in quality, health economics, and value-based purchasing concepts
10
ADVI.COM
202 509 0760
610 10TH STREET N.W.
SUITE 400
WASHINGTON, DC 20001
WASHINGTON DC
AUSTIN
SAN FRANCISCO
11
Download